Macrophages promote both injury and repair after myocardial infarction, but discriminating functions within mixed populations remains challenging. Here we used fate mapping, parabiosis and single-cell transcriptomics to demonstrate that at steady state, TIMD4 + LYVE1 + MHC-II lo CCR2 − resident cardiac macrophages self-renew with negligible blood monocyte input. Monocytes partially replaced resident TIMD4 -LYVE1 -MHC-II hi CCR2 − macrophages and fully replaced TIMD4 − LYVE1 − MHC-II hi CCR2 + macrophages, revealing a hierarchy of monocyte contribution to functionally distinct macrophage subsets. Ischemic injury reduced TIMD4 + and TIMD4resident macrophage abundance, whereas CCR2 + monocyte-derived macrophages adopted multiple cell fates within infarcted tissue, including those nearly indistinguishable from resident macrophages. Recruited macrophages did not express TIMD4, highlighting the ability of TIMD4 to track a subset of resident macrophages in the absence of fate mapping. Despite this similarity, inducible depletion of resident macrophages using a Cx3cr1-based system led to impaired cardiac function and promoted adverse remodeling primarily within the peri-infarct zone, revealing a nonredundant, cardioprotective role of resident cardiac macrophages.
Division of Cardiology, Washington University School of Medicine, St Louis, MO, USA. 9 John Cochran VA Medical Center, St Louis, MO, USA. 10 Peter Munk Cardiac Centre, Toronto, Canada. 11 These authors contributed equally: Sarah A. Dick, Jillian A. Macklin, Sara Nejat. *e-mail: slava.epelman@uhn.ca I schemic cardiovascular disease remains the leading cause of mortality worldwide 1 . After a myocardial infarction, an inflammatory response is directed to the site of injury, resulting in structural and biochemical changes that can lead to adverse cardiac remodeling and dysfunction manifesting clinically as heart failure 2 . Macrophages are specialized mononuclear phagocytes that reside in all tissues from the earliest stages of development and have particularly important roles in the response to injury [3] [4] [5] [6] . The mammalian neonatal heart has a remarkable capacity to fully regenerate after injury 7 . Clodronate liposomal depletion of neonatal macrophages prevents regeneration, in part through macrophage-specific expression of growth factors such as IGF-1 and other mechanisms yet to be characterized [8] [9] [10] . After ischemic injury in adult mice, both excessive numerical expansion of macrophages 8, 11 and nonselective depletion of macrophages 12 limit cardiac repair through excessive inflammatory tissue damage and impaired scar formation, respectively. Macrophage composition in tissue is both heterogeneous at steady state and highly dynamic after injury. Within the adult heart, the majority of resident cardiac macrophages originate from embryonic development, both from early embryonic day 8.5 (E8.5) erythromyeloid progenitors and also later from fetal monocytes 5 . The relative contributions of erythromyeloid progenitor cell-derived fetal liver monocytes and emerging hematopoietic stem cell-derived mono-cytes to the adult CD64 + cardiac macrophage pool are not known. However, after birth, the slow recruitment of invading monocytederived macrophages from circulation leads to competition for tissue residency, and it is not clear whether monocyte-independent populations remain 13 .
Circulating monocytes express CCR2, a chemokine receptor important for migration 14 , and are enriched in components of the NLRP3 inflammasome. After tissue injury, CCR2 + monocytes and macrophages can produce IL-1β 5 , a pro-inflammatory cytokine that promotes cardiovascular disease 15 . In contrast, resident CCR2 − macrophages are primarily of embryonic origin and promote angiogenesis and cardiomyocyte proliferation, similar to neonatal macrophages 8, 9, 16 . However, beyond these observations, more-detailed understanding of cardiac macrophage heterogeneity is lacking.
Here we investigated cardiac macrophage heterogeneity at steady state, plasticity after infarction and the role of resident macrophages in repair. Through the combined use of genetic fate mapping, longterm parabiosis studies and single-cell RNA sequencing (scRNAseq), we observed that the healthy adult myocardium contains four populations of macrophages, including a subset that is maintained independently of blood monocytes (TIMD4 + LYVE1 + MHC-II lo CCR2 -), a subset that is partially replaced by monocytes Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction Cluster 5 was enriched in many interferon-stimulated genes such as Irf7, Isg20 and Ifit1 (termed the Isg cluster; Fig. 1d,f) .
We performed pathway analysis by individually comparing the Timd4 cluster to other clusters. Timd4 cluster pathways were focused on homeostatic and regenerative functions; that is, endocytosis, lysosome function, angiogenesis and regeneration ( Fig. 1g ). Relative to the Timd4 cluster, translational-ribosomal pathways were strongly upregulated in the Mhc-II, Ccr2 and Isg clusters, whereas classic inflammatory pathways, including respiratory burst, response to interleukin 12, interferon-γ and type I interferon, were enriched in the Ccr2 and Isg clusters (Fig. 1g) . These data reveal the existence of unique, cluster-specific functions in macrophages at steady state.
Single-cell trajectories reveal developmental relationships.
To determine whether hypothetical developmental relationships exist between monocytes and macrophage clusters, we reclustered these populations (clusters 1-5) to provide trajectories of single cell-based changes in gene expression ( Fig. 2a ). Seurat-defined clusters were superimposed on a pseudotime trajectory produced by the Monocle 24 algorithm, which revealed that macrophages in the Timd4 cluster occupied a separate trajectory branch (B1; Fig. 2b ). Monocytes and macrophages found in the Ccr2 and Isg clusters occupied a second branch (B2; Fig. 2b ), whereas macrophages in the Mhc-II cluster straddled all three branches (B3; Fig. 2b ). The Mpath 25 algorithm demonstrated similar ordering, suggesting that macrophages in the Isg cluster could arise from the Ccr2 cluster, rather than monocytes ( Fig. 2c ), which was confirmed by a restricted Monocle analysis (Fig. 2d ).
Gene expression was then plotted as a function of pseudotime in Monocle to track changes across different macrophage states. Klf2, Mafb and Maf expression was low in the Ccr2 cluster, higher in the Mhc-II cluster and even greater in the Timd4 cluster ( Fig. 2e,f ), suggesting that these transcription factors tracked with cardiac macrophage fate. Loss of expression of the Mhc-II cluster genes Cx3cr1 and Il1b was associated with gain of Timd4, Lyve1 and Igf1 expression in the Timd4 cluster ( Fig. 2e,f) , which was the most transcriptionally distinct subset. In contrast, the Ccr2, Mhc-II and Isg clusters seemed to make up a spectrum of related lineages, with the Isg cluster adopting a unique activation state focused around type I interferon signaling. Tracking gene expression changes across macrophage states revealed coordinated patterns defining macrophage subset identification and functions.
Cx3cr1-based mapping tracks resident cardiac macrophage fate. To track cardiac macrophages that are maintained independently of blood monocytes, we used a mouse line with tamoxifeninducible Cx3cr1 CreERT2-IRES-YFP (termed Cx3cr1 CreER-YFP ) controlled by the endogenous Cx3cr1 promoter 26 crossed with Rosa26-stop-TdTomato reporter mice (termed Cx3cr1 CreER-YFP :R26 Td ; Fig. 3a ). Earlier studies have shown robust tamoxifen-inducible reporter gene expression in Cx3cr1-expressing resident macrophages and transient labeling of blood monocytes 13, 26, 27 . We fed tamoxifen-containing chow to 3-week-old mice for 10 d, followed by normal chow for 1-10 weeks. Labeling of CD115 + CD11b + Ly6c + blood monocytes before tamoxifen administration was negligible (< 0.2% Td + ). Ly6c + blood monocytes were efficiently labeled (92-95% Td + ) immediately after tamoxifen administration, and labeling returned to baseline 2-3 weeks after tamoxifen discontinuation (< 0.5%; Fig. 3b ). More than 90% of total CD11b + CD64 + cardiac macrophages were Td + immediately after tamoxifen administration (Fig. 3b ). Over a 5-week period, CCR2cardiac macrophages retained Td expression, whereas CCR2 + cardiac macrophages gradually lost Td expression after tamoxifen discontinuation ( Fig. 3b ), consistent with replacement of CCR2 + macrophages by unlabeled monocytes.
To further assess macrophage turnover based on scRNA-seq cluster-defining markers, we labeled resident cardiac macrophages Monocyte cluster (4)
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(as in Fig. 3b ) and analyzed them 20 weeks after tamoxifen discontinuation. CCR2 -MHC-II lo TIMD4 + cardiac macrophages retained high Td reporter expression (~90% Td + ) after tamoxifen discontinuation and had very little donor chimerism (~2%) in parabiotic studies ( Fig. 3c,d ). The other two subsets had progressively higher turnover. CCR2 -MHC-II hi TIMD4 − macrophages were ~75% Td + , with ~20% chimerism by parabiosis, whereas CCR2 + MHC-II hi TIMD4macrophages were about 15-20% Td + , with almost complete chimerism (~90%) in parabiotic studies ( Fig. 3c,d) . Thus, CCR2 expression alone identified a subset of cardiac macrophages that were fully replaced by blood monocytes in adult mice, and by stratifying the remaining macrophages by TIMD4 
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and MHC-II, we identified macrophage subsets with limited monocyte dependence. Next we examined Td reporter expression in tissue macrophages in Cx3cr1 CreER-YFP :R26 Td mice from birth to adulthood without tamoxifen or with tamoxifen injected at E18.5. In the absence of tamoxifen, Td + macrophages were detected in resident macrophage populations that express Cx3cr1 immediately after birth (that is, microglia and cardiac macrophages) ( Supplementary Fig. 2a ). Background Td expression reached a relative plateau of ~25% of total cardiac macrophages between 8 weeks and 13 weeks of age. Tissue macrophages with low expression of Cx3cr1 (such as liver Kupffer cells) had very low Td expression (0-5%), and there was virtually no Td expression in blood monocytes at any time point examined (E18.5, 35 weeks of age) in the absence of tamoxifen. 11-weekold mice treated with tamoxifen at E18.5 had high Td expression in brain microglia (~99%) and cardiac macrophages (~80%) and lower expression in liver Kupffer cells (~40%; Supplementary  Fig. 2a ). We also observed similar Td reporter expression in the absence of tamoxifen in cardiac macrophages and brain microglia from an independently generated Cx3cr1 CreERT2 line 27 bred to the same R26 Td reporter ( Supplementary Fig. 2b ).
To investigate whether monocyte-derived macrophages could be induced to express the Td reporter, we isolated Td − bone marrow from adult CD45.2 + Cx3cr1 CreER-YFP :R26 Td mice and reconstituted sublethally irradiated CD45.1 + recipients. At 6 weeks after reconstitution, CD45.2 + monocytes and monocyte-derived cardiac CD45.2 + macrophages were Td -(~98%; Supplementary  Fig. 2c ), indicating that Cx3cr1 CreER-YFP :R26 Td monocytes do not induce the expression of the Td reporter upon macrophage differentiation in the absence of tamoxifen. Thus, although some macrophage populations in Cx3cr1 CreER-YFP :R26 Td expressed Td in the absence of tamoxifen administration, Td reporter activity reliably distinguished resident cardiac macrophages from recruited, monocyte-derived macrophages.
Resident macrophages are lost within infarcted myocardium. To examine resident macrophage dynamics during sterile injury, we used a model of myocardial infarction through surgical ligation of the left anterior descending artery 5 . Cardiac tissue was analyzed by flow cytometry at different times after injury in the ischemic zones (infarct and peri-infarct tissue) and the remote (noninfarcted) zones of Cx3cr1 CreER-YFP :R26 Td mice fed tamoxifen at 3 weeks of age for 10 d (Fig. 4a ). Tamoxifen was discontinued for 6 weeks before mice were infarcted. The absolute number of resident Td + macrophages in the ischemic zone was reduced by ~60% after infarction (day 2) compared to noninfarcted mice ( Fig. 4b ), including both resident CCR2 − MHC-II lo TIMD4 + and CCR2 − MHC-II hi TIMD4macrophages ( Supplementary Fig. 3a ). Absolute numbers of resident Td + macrophages slowly increased after infarction (days 4-28), compared to day 2, whereas the number of recruited Td − macrophages decreased. However, the ratio of resident macrophages to recruited macrophages did not return to preinfarct levels by 4 weeks after infarction ( Fig. 4c,d ). Resident CCR2 − MHC-II hi TIMD4macrophages were ~75% Td + at steady state, but after infarction, only ~5% remained Td + , indicating that recruited macrophages made up the vast majority ( Fig. 4e ). In contrast, resident 
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CCR2 − MHC-II lo TIMD4 + macrophages were ~90% Td + at baseline, and after infarction they remained at ~75% Td + at days 2 and 28 ( Fig. 4e ), indicating that TIMD4 expression was maintained on resident Td + macrophages and recruited macrophages did not become TIMD4 + , even at 28 d after infarction. Immunofluorescence imaging also indicated a 70% loss of Td + cardiac macrophages in the infarct zone at day 2 after infarction, compared to noninfarcted hearts, with a progressive increase in density over 28 d (Fig. 4f ). Increased resolution of the infarct region versus the peri-infarct region demonstrated a region-specific increase in the absolute number of Td + cardiac macrophages in the peri-infarct zone at days 2 and 7 after infarction, compared to control noninfarcted heart tissue. LYVE1 was coexpressed on TIMD4 + macrophages, as determined by flow cytometry ( Supplementary  Fig. 3b ), and was highly expressed within the Timd4 cluster, as determined by scRNA-seq ( Fig. 1f ). We partitioned resident macrophages into CD68 + LYVE1 + Td + and CD68 + LYVE1 -Td + macrophages in the cardiac tissue sections ( Supplementary Fig. 3c ). LYVE1 -Td + macrophages increased in number in the peri-infarct zone at day 2 after myocardial infarction, compared to noninfarcted control, whereas the number of LYVE1 + Td + macrophages did not change ( Supplementary Fig. 3c ), highlighting spatial enrichment of resident LYVE1 − macrophages in the peri-infarct zone.
We assessed macrophage proliferation in vivo after infarction by administering BrdU intraperitoneally (i.p.) 2 h before isolation to label cells in S-phase 5 . We observed a proliferative burst in resident Td + cardiac macrophages at days 2 and 4 after infarction, compared to noninfarcted hearts, whereas recruited Td − macrophages exhibited increased proliferation only at day 4 after infarction ( Fig. 4g,h) . When parsing resident Td + macrophages into TIMD4 + and TIMD4 − subsets, we observed a slight proliferative advantage of resident Td + TIMD4 − macrophages ( Supplementary  Fig. 3d ); this supports the observation that the analogous resident Td + LYVE1 − subset increased in cell number in the peri-infarct region ( Supplementary Fig. 3c ).
To ensure that Tdblood monocytes did not differentiate into Td + macrophages after recruitment into the cardiac tissue after infarction (in the absence of tamoxifen), we produced chimeric mice in a CD45.1 + background that contained CD45.2 + Cx3cr1 CreER-YFP :R26 Td monocytes through either parabiosis ( Supplementary  Fig. 4a ) or bone-marrow transfer after chest wall-shielded irradiation ( Supplementary Fig. 4b ). Myocardial infarction was induced at 2 weeks after parabiosis or 6 weeks after bone marrow transfer, and cardiac tissue was analyzed by flow cytometry at 5 d or 28 d, respectively, after myocardial infarction. CD45.2 + monocytes and monocyte-derived macrophages isolated from CD45.1 + mice did not induce Td expression after recruitment post-infarction in the absence of tamoxifen ( Supplementary Fig. 4a,b ). To confirm tamoxifen responsiveness in these two systems, we assessed CD45.2 + macrophages from donor parabiotic mice and bone marrow chimeras injected with tamoxifen before isolation, and both showed large numbers of Td + macrophages. Thus, in the inflammatory environment after irradiation or myocardial infarction, the Cx3cr1 CreER-YFP :R26 Td line retained the ability to distinguish resident from recruited cardiac macrophages.
Recruited cardiac macrophage plasticity in infarcted tissue. To explore macrophage heterogeneity after ischemic injury, we performed scRNA-seq on CD45 + CD11b + CD64 lo-hi macrophages from Cx3cr1 CreER-YFP :R26 Td mice treated with tamoxifen at E18.5 and infarcted at 7 weeks of age. Macrophages were isolated from the ischemic zone 11 d after infarction ( Fig. 5a ). At 11 d after myocardial infarction, the acute inflammatory response is resolved and recruited monocytes have differentiated into tissue macrophages 28-30 , making it an ideal time point to study macrophage heterogeneity. We sequenced 1,806 cells from control noninfarcted mice and 4,697 cells from the ischemic zone after infarction. t-SNE analysis of noninfarcted mice revealed six clusters identical to those previously identified (Timd4 cluster, Mhc-II cluster, Ccr2 cluster, Isg cluster, proliferating macrophages and monocytes; Fig. 5b ). In macrophages isolated from infarcted tissue, we identified 13 clusters, 6 of which precisely overlapped the 6 clusters identified in noninfarcted hearts, and 7 clusters were unique to infarcted tissue (Fig. 5b) . Approximately 64% of the macrophages sequenced after infarction fell in unique clusters (Fig. 5b,c) , indicating that the majority of macrophages evolved distinct transcriptional signatures compared to noninfarcted tissue.
Post-infarct macrophages from individual overlapping clusters had nearly identical gene expression patterns compared to macrophages of the same cluster in the noninfarcted control sample, except for a total of 67 genes (sum across all overlapping clusters; Fig. 5d ,e; Supplementary Fig. 3e and Supplementary Table 1 ). Genes associated with mature macrophages (Lyve1, Timd4, Retnla, Cd163, Folr2 and Klf2) were downregulated, whereas genes associated with monocytes (Ms4a7 and Spp1) were upregulated in post-infarction macrophages, compared to noninfarcted control macrophages ( Fig. 5f ). Classic macrophage genes (Adgre1, Fcgr1 and C1qa) remained unchanged, as did the vast majority (7,543) of other genes detected in each overlapping cluster ( Fig. 5d-f ). Macrophages expressing the transcript encoding Td were found in control noninfarcted mice at a frequency much lower (~13%) than expected based on flow cytometric analysis (~80% Td + , Supplementary Fig. 2a ); this limited our ability to track resident populations by scRNA-seq. However, similar to the results obtained from flow cytometric analysis, there was a decrease in both the absolute number and percentage of Td-expressing macrophages in both the post-infarct overlap and post-infarct unique clusters, compared to the noninfarcted clusters (> 90% loss of Td-expressing macrophages; Fig. 5g ). These data suggest that after infarction, macrophages that were found in overlapping clusters (clusters 1-6) were mainly derived from Tdmonocytes, yet they had nearly identical transcriptional signatures as macrophages in steady-state control mice, with the exception of a very small number of core genes found in resident macrophages, such as Timd4, Lyve1, Igf1 and Folr2 (Fig. 5f ).
Among the seven unique post-infarct macrophage clusters, differential gene expression analysis and comparison to the ImmGen database identified four macrophage clusters (8) (9) (10) (11) and one dendritic cell cluster (7; CD209a cDC2s) (Fig. 5b,c and Supplementary  Fig. 3e,f) . Compared to the overlapping clusters, macrophages in unique clusters 8-11 were enriched most strongly in inflammatory pathways (response to interferon-γ ; monocyte chemotaxis) but also in some reparative pathways ( Fig. 5h ; Supplementary Table 2 for all cluster-specific genes). Cluster 6 was composed of three subclusters (6a-6c) that clustered separately (Fig. 5b) . Monocle trajectory analysis revealed three different fates along the same developmental trajectory, with a progressive increase in the expression of macrophage genes and a reciprocal loss in the expression of monocyte genes (Fig. 5i ). We also observed the progressive upregulation of pathways involved in hypoxia (HIF-1α signaling; P = 1.4 × 10 -3 ), glycolytic metabolism (P = 0.02) and extracellular matrix interactions (P = 1.6 × 10 -3 ) as monocytes transitioned into macrophages (Fig. 5j) , consistent with the anaerobic environment of ischemic tissue. Therefore, although recruited macrophages had a high degree of plasticity, they did not adopt the core transcriptional signature of resident populations and could be distinguished by flow cytometry and scRNA-seq.
Cardiac macrophage heterogeneity in human cardiomyopathy.
Next we sorted human cardiac CD45 + CD64 + CD14 + macrophages from subjects with cardiomyopathies. Based on MHC-II (HLA-DR) and CCR2 expression, we identified three subsets, CCR2 − MHC-II hi , CCR2 + MHC-II hi and CCR2 + MHC-II lo ( Supplementary Fig. 5a,b) , Cardiac tissue from control mice and from infarcted mice was isolated (ischemic zone, 11 d after MI). a, Live cardiac CD45 + CD64 Dim-Hi CD11b + macrophages were sorted and processed for scRNA-seq as in Fig. 1c (1,806 control cells; 4,697 post-MI cells). One experiment, two mice or four mice pooled for the control group and MI group, respectively. b, Seurat-based t-SNE analysis of merged control and post-MI samples reveals 'overlapping clusters' present in both control samples and post-MI samples, and 'unique clusters', present only post-MI. c, Heatmap of the top 20 differentially expressed genes per cluster post-MI. d, t-SNE plot depicting cells in control sample (pink), and cells in MI sample that overlapped control (MI overlap; green) and cells uniquely found after MI (MI unique; blue). e, Pie chart illustrating number of differentially expressed genes between control and MI-overlap groups, relative to number of commonly expressed genes between these two groups (see Supplementary Table 1 for differentially expressed genes per cluster). f, Representative violin plots of differentially expressed genes among the three populations as defined in Fig. 5d ; **P < 10 -13 (adjusted for multiple comparisons). g, Absolute number and percentage of Td-expressing cells in each cluster defined in Fig. 5d . h, Pathway analysis (gProfiler) of differentially expressed genes in MI-overlap versus MI-unique populations. Pathway enrichment is expressed as the -log[P] adjusted for multiple comparison. i, A pseudotemporal trajectory (Monocle) analysis of cluster 6 subsets (Fig. 5b) demonstrates a linear developmental progression from cluster 6a (monocyte) to 6c (macrophage). j, Violin plots of differentially expressed genes in cluster 6, including HIF-1α and glycolysis pathway genes. *P < 10 -2 . Statistical analysis for scRNA-seq data is described in Methods.
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that seemed to be similar to mouse cardiac macrophages. Differentially expressed genes defined by murine t-SNE clusters were used to determine whether sorted human cardiac macrophage populations expressed similar patterns. The human CCR2 -MHC-II hi macrophages expressed many genes found in the murine Timd4 cluster, including TIMD4, LYVE1, CD163, FOLR2, IGF1 and MAF ( Supplementary Fig. 5c ). Murine gene signatures associated with the Isg cluster, the Ccr2 cluster and monocytes were found predominantly in human CCR2 + MHC-II lo monocytes and CCR2 + MHC-II hi macrophages. Only 226 genes were differentially expressed between human CCR2 -MHC-II hi and human CCR2 + MHC-II hi macrophages, with the majority (179 genes) upregulated in CCR2 + MHC-II hi macrophages ( Supplementary Fig. 5c ). Pathway analysis indicated that human CCR2 + MHC-II hi macrophages were enriched in hematopoietic stem cell lineage genes (P = 2.8 × 10 -6 ), cytokine-cytokine receptor interactions (P = 4.6 × 10 -5 ) and Toll-like receptor signaling (P = 2.9 × 10 -2 ), whereas human CCR2 -MHC-II hi cardiac macrophages were enriched in the complement cascade (47 genes upregulated; P = 4.4 × 10 -2 ). Thus, CCR2 defines recruited monocytes and monocyte-derived macrophages in both mouse models and human cardiomyopathy.
Cx3cr1-based depletion post-infarct worsens cardiac function.
Next we used Cx3cr1 CreER-YFP :R26 Td/DTR mice to label resident macrophages with both the Td reporter and the diphtheria toxin receptor (DTR) to selectively deplete resident Td + cardiac macrophages through diphtheria toxin injection without affecting other cell types ( Supplementary Fig. 6a,b ). Diphtheria toxin injection alone, in the absence of ischemic injury, did not cause any detectable recruitment of neutrophils and macrophages, nor did it cause cardiac fibrosis in wild-type mice that did not contain DTR ( Supplementary Fig. 6c ).
To test the functional role of resident macrophages after infarction, we fed 3-week-old Cx3cr1 CreER-YFP :R26 Td/DTR mice tamoxifen chow for 10 d, and tamoxifen was discontinued for 6 weeks. Daily diphtheria toxin injections were started 1 d before myocardial infarction to deplete and suppress the numerical recovery of resident cardiac macrophages (Fig. 6a,b ). There was no difference in the infarct size or cardiac function at day 7 after infarction in diphtheria toxintreated Cx3cr1 CreER-YFP :R26 Td/DTR mice, compared to Cx3cr1 CreER-YFP :R26 Td/+ mice, which lacked the DTR (Fig. 6c,d ). However, global left ventricular systolic function deteriorated between days 7 and 28 after infarction, with increased cardiac hypertrophy, fibrosis and increased late mortality by day 35 after infarction in diphtheria toxin-treated Cx3cr1 CreER-YFP :R26 Td/DTR mice, compared to Cx3cr1 CreER-YFP :R26 Td/+ mice ( Fig. 6e-i ). There was no significant change in the magnitude of the inflammatory response in macrophage-depleted mice, compared to nondepleted (Cx3cr1 CreER-YFP :R26 Td/+ ) mice, at day 5 after infarction ( Supplementary Fig. 6d ), indicating that depletion of resident macrophages did not cause an exaggerated inflammatory response acutely.
Although the absolute number of resident CD64 + Td + cardiac macrophages was similar between noninfarcted controls and postinfarct hearts in the remote zone at all time points analyzed, there was increased recruitment of monocytes and monocyte-derived CD64 + Tdmacrophages in this area at days 2, 4 and 7 after infarction ( Supplementary Fig. 6e ). However, CD64 + Td + resident macrophages proliferated robustly in this region, as determined by BrdU incorporation, at days 2 and 4 after infarction ( Supplementary  Fig. 6f ). Depletion of resident cardiac macrophages led to a decrease in left ventricular systolic function from day 7 to day 28 after infarction in the remote zone of diphtheria toxin-treated Cx3cr1 CreER-YFP :R26 Td/DTR mice, compared to no change in infarcted nondepleted Cx3cr1 CreER-YFP :R26 Td/+ mice ( Supplementary Fig. 6g ). We also observed an increase in cardiomyocyte hypertrophy, but no change in cardiac fibrosis, in the remote zone of depleted compared to nondepleted hearts 35 d after infarction ( Supplementary   Fig. 6h,i) . These data indicate a spatially restricted, primary role for resident Td + macrophages in the peri-infarct zone to prevent pathological remodeling and the development of global left ventricular dysfunction in the surviving myocardium.
Discussion
Here we describe the transcriptional and functional heterogeneity that exists within the innate immune cell compartment of the murine heart, both at steady state and after myocardial infarction. Through a combination of cell tracking and scRNA-seq, we found that the healthy murine myocardium contains four transcriptionally distinct cardiac macrophage subsets with subset-specific life cycles and function. Resident cardiac macrophages accounted for only 2-5% of the total cardiac macrophages within the infarct zone during the first few weeks after infarction, yet their depletion impaired cardiac function and worsened infarct healing. This is underscored by the observation that nearly identical, recruited macrophages were present at nearly the same time yet did not compensate for resident macrophage depletion. A small number of cluster-specific, resident macrophage genes (such as Timd4, Lyve1 and Igf1) were not adopted by recruited macrophages, and these genes could have endowed resident macrophages with critical reparative functions. For instance, the phosphatidylserine receptor TIMD4 is used by macrophages in efferocytosis 17 , without which ischemic injury is amplified 31 . LYVE1 binds hyaluronan expressed by smooth muscle cells and has an integral role in vascular homeostasis 32 ; therefore, loss of LYVE1 + macrophages could disrupt adaptive healing mechanisms. The growth factor IGF1, which is secreted by cardiac macrophages, directly promotes angiogenesis 10 . Alternatively, by the time monocytes become peripherally derived resident macrophages, they might have missed the window of opportunity for providing effective cardioprotective functions. Additional studies using Cx3cr1-based strategies to target resident macrophages would shed light on which, if any, of these potential mechanisms are involved.
During neonatal cardiac injury, cardiac macrophages proliferate 5, 8 . In contrast, ischemic injury in adult mice reduced the abundance of resident Td + cardiac macrophages within infarcted tissue, presumably through cell death due to anoxia and nutrient deprivation. After infarction, a robust proliferative program was triggered in the remaining resident macrophages, similar to that in neonatal cardiac macrophages. Importantly, the neonatal myocardium did not recruit monocytes in significant numbers; this is fundamentally different than in the adult myocardium 8 . The limited capacity to recruit monocytes in large numbers may be an adaptive mechanism that promotes reparative programs inherent to resident, embryonicderived macrophages during development. The density of peripherally derived CCR2 + cardiac macrophage is correlated with cardiac dysfunction after heart transplantation in humans. In addition, preventing monocyte influx in adult mice has beneficial effects when excessive inflammation drives ischemic injury 33, 34 . Paradoxically, our data indicate that inhibiting monocyte influx alone could impair development of monocyte-derived macrophages with reparative functions and prevent replacement of reparative resident populations that are lost during the initial insult.
Understanding the tissue-specific cues that drive monocyte fate selection during ischemic injury will be critical in influencing reparative pathways. However, it remains to be clarified whether the nine macrophage clusters found after infarction specify their fate when they enter the myocardium, whether these clusters are at their final transcriptional destinations, or whether they are part of a continuum. Notably, there is evidence that monocyte fate selection occurs not only in tissues but also in the bone marrow. Hematopoietic stem cells produce lineage-committed monocytes before release into circulation, and these monocyte lineages have distinct tissue functions, presumably through epigenetic changes. For example, Ly6C lo MSR1 + CEACAM1 + blood monocytes enter the Articles NaTuRE IMMuNoLogY lungs and promote tissue fibrosis, Ly6C hi CD209a + monocytes preferentially differentiate into monocyte-derived dendritic cells 35, 36 , and immunoregulatory Ym1 + Ly6C hi monocytes are released only in the recovery phase after injury and promote tissue repair 37 .
Earlier studies have suggested that resident cardiac macrophages are slowly replaced by monocyte-derived populations 13 . However, our data suggest that cardiac macrophages must be stratified appropriately for full understanding of their life cycle. CCR2 -MHC-II lo TIMD4 + LYVE1 + macrophages have negligible monocyte input at steady state and even in chronically infarcted tissue. The identification of Timd4 and Lyve1 expression in resident macrophages from other tissues suggests that they may represent important resident macrophage markers [38] [39] [40] . Specifically in the myocardium, TIMD4 and LYVE1 may be used to identify resident macrophages in the absence of dedicated tracking approaches. Given enough time, tissue cues may prompt recruited macrophages to ultimately express genes such as Timd4 and Lyve1. This possibility is evident based on adoptive transfer experiments in the peritoneum and lungs, where the tissue guides the identity of the transferred macrophage population 41, 42 . Our study highlights the complexity and plasticity underlying recruited and resident cardiac macrophages at steady state and particularly within infarcted tissue. Greater understanding of this 3-week-old Cx3cr1 CreER-YFP : R26 Td/DTR mice were fed tamoxifen-chow for 10 d, tamoxifen was discontinued for 6 weeks, and mice either were noninfarcted (no MI) or received surgical MI. Mice that received a surgical MI were injected daily with either PBS (MI control) or 250 ng diphtheria toxin (MI depleted), starting the day before surgery. a,b, Representative flow cytometric plots (a) of CD45 + CD64 + CD11b + macrophages, demonstrating the number of Td + cells remaining at day 35 after infarct within the ischemic zone, and quantified (b) in both the ischemic zone and remote zone by flow cytometry per mg of tissue. Resident macrophages were identified as CD64 + CD11b + Td + . n values (left to right throughout): 3, 7. Experiment was repeated twice; representative plot is shown. c, Infarct size was measured at day 7 after MI by echocardiography, reported as percentage akinetic area. n = 11. Experiment was repeated twice with similar results. d, Percentage of left ventricular ejection fraction (LVEF) measured at day 7 after MI. n = 11. Experiment was repeated twice with similar results. e, Average change in ejection fraction from day 7 to day 28 post-MI (Δ LVEF). n = 4, 11, 11. Repeated two times with similar results. f, Cardiac hypertrophy 35 d after MI, as measured by heart weight (HW) to body weight (BW) ratio. n = 9, 11, 11. Experiment was repeated twice with similar results. g, Histological cross-section (left) and quantification (right) of the cardiac peri-infarct zone at day 35 after MI. Hearts were scanned at 10× magnification. Percentage fibrotic area was quantified using Fast Green staining and ImageJ analysis, with four images per zone per heart in two sections, 150 μ m apart. n = 9. Experiment was repeated once. h, Kaplan-Meier curve representing percentage survival at day 35 post-MI. n = 17. Experiment was repeated twice with similar results. i, Cardiomyocyte hypertrophy, assessed with wheat germ agglutinin staining in the peri-infarct zone. Hearts were imaged at 20× magnification and cardiomyocyte area was measured in ImageJ, with eight images per zone per heart at two cutting levels. n = 4, 6, 6. Experiment was repeated once. For all: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; Two-tailed Student's t-test; center value, mean; error bars, s.e.m.
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dynamic process is required to delineate the probably differential contribution of individual macrophage subsets to tissue repair and injury, so that effective therapeutic strategies can be generated.
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Methods
Mice. All mice used in this study were purchased from The Jackson Laboratory and were bred in our animal facility before use. All mice were bred and housed in a pathogen-free environment at the University Health Network Animal Facility and were fed standard rodent chow. All experimental procedures were approved by the Animal Care Committee of the Toronto General Research Institute and were performed according to the guidelines of the Canadian Council on Animal Care.
Fate mapping. To induce recombination in Cx3cr1 CreER-YFP :R26 Td mice, tamoxifen was administered via tamoxifen-containing chow (Envigo) for 11 d or injected into pregnant females at E18.5 via i.p. injection at 2 mg per mouse. For tamoxifen preparation, 100 mg of tamoxifen-free base (Sigma-Aldrich T5648) was added to 0.5 ml 95% ethanol; 9.5 ml corn oil was then added to the mixture and the mixture was vortexed and sonicated until the oil was dissolved.
Macrophage depletion. Diphtheria toxin (Sigma) was diluted in PBS and administered to mice i.p. acutely (500 ng daily for 3 consecutive days) or chronically (500 ng daily for 3 consecutive days, then 250 ng daily, 3× weekly for 2 additional weeks). For the long-term depletion and functional experiment, 500 ng diphtheria toxin was administered i.p. daily for the first 7 d, followed by 250 ng i.p. daily until 35 d after myocardial infarction.
Human samples. Human cardiac tissue samples were obtained from the Washington School of Medicine from subjects with end-stage cardiomyopathy during the time of implantation of the left ventricular assist device. Informed consent was received from all subjects and approved by the Washington University Institutional Review Board, with compliance to all relevant ethical regulations. After left ventricular apical core segment was removed, before placement of the inlet cannula, the cardiac tissue was immediately placed into cold RPMI medium. Human cardiac tissue was minced and digested in a fashion identical to that for mouse cardiac tissue.
Cell visualization. To visualize human macrophage subset cell morphology, hearts were harvested, digested and prepared for flow cytometry. Sorted cells (AriaIII-CFI BRVY) were cytospun onto slides and stained with Hema3 (Fisher Scientific). Cells were imaged with a Zeiss Axioscope at 20× .
Gene expression analysis.
RNA from human cardiac macrophages was extracted from Trizol samples using the Qiagen micro-kit (Qiagen) as we previously described 4 . Total RNA concentration and quality was determined by Agilent 2100 Bioanalyzer (Agilent Technologies) according to the manufacturer's recommendations.
Transcriptional array. RNA transcripts were first amplified by WTA2 kit (Sigma Aldrich). Total RNA (1 ng) was amplified according to the manufacturer's protocol. cDNAs were chemically labeled with Kreatech ULS labeling kit (Kreatech Diagnostics). Per reaction, 2.5 μ g of DNA was mixed with Kreatech labeling buffer and Kreatech Cy5-ULS 4 . The reactions were incubated at 85 °C for 15 min in the dark and placed on ice for 3 min. Labeled DNAs were purified with QIAquick PCR purification columns (Qiagen Sciences). Labeled DNAs were quantified on a Nanodrop spectrophotometer. Each labeled DNA (2 μ g) was suspended in Agilent 2X Gene Expression hybridization buffer, Agilent 10X Blocking agent and Kreatech Kreablock. The hybridization solutions were applied to Agilent Human 4 × 44K V1 microarrays. Hybridization was carried out at 65 °C for 20 h. Washing procedures were carried out according to Agilent gene expression protocols. Slides were scanned on an Agilent SureScan microarray scanner to detect Cy5 fluorescence. Gridding and analysis of images were performed using Agilent Feature Extraction v10.7.3.1. Background-subtracted, log-transformed, quantile-normalized data were analyzed using analysis of variance (ANOVA) testing with contrasts (Partek GS, Partek). For exploratory analyses, we set the threshold at a two-fold change with an unadjusted P = 0.001.
Tissue isolation and cell-surface staining. Mice were killed by CO 2 inhalation. Hearts were perfused with 20 ml of cold PBS. Hearts, lungs, livers and brains were chopped finely and digested, while being shaken, for 1 h at 37 °C in DMEM containing collagenase I (450 U ml -1 ), DNase I (60 U ml -1 ) and hyaluronidase (60 U ml -1 ) enzymes (all from Sigma) 30 . The digested material from heart, liver and brain was filtered through 40 μ M filters and pelleted by centrifugation (400g for 5 min at 4 °C) in Hank's balanced salt solution (HBSS) supplemented with 2% bovine serum + 0.2% BSA. Red blood cells were lysed in ACK lysis buffer (Invitrogen) for 5 min at room temperature and resuspended in FACS buffer (PBS containing 2% FCS and 2 mM EDTA). Liver was filtered and resuspended in 40% Percoll. Brain was filtered and resuspended in 40% Percoll mixed on top of 80% Percoll. Pellets were resuspended, red blood cells were lysed and samples were resuspended as described above. Finally, blood was collected in syringes containing 50 μ l heparin, red blood cells were lysed, and pellets were resuspended as described above. Single-cell suspensions were then labeled for cell-surface markers using antibodies listed below (in the 'Mouse antibodies' paragraph in the 'Flow cytometry gating strategy and antibodies' subsection). Cells werelabeled in 50 μ l FACS buffer with 0.2 μ l antibody per sample, with the exception of the antibody to CCR2 (5 μ l), for 30 min at 4 °C. Cells were washed and resuspended in 400 μ l FACS buffer to be analyzed by flow cytometry (BD LSRII-OICR BGRV). For more information about tissue isolation, digestion and flow cytometric analysis, please review uploaded video content (https://www.jove.com/video/58114/isolation-identificationextravascular-immune-cells) 43 .
BrdU incorporation. For proliferation experiments, 2 mg of BrdU (Sigma) was injected i.p. at 2 h before organ harvest as described 5 . To detect intracellular BrdU, the BD Bioscience Cytofix/Cytoperm protocol was used. Cells were fixed after cell surface labeling, washed and resuspended with permeabilization buffer overnight. DNA was digested for 1 h with DNase (Sigma), cells were labeled with Fc receptor-blocking reagent for 15 min and were then labeled with an antibody to BrdU for 30 min.
Flow cytometry gating strategy and antibodies. After gating on CD45 + cells, doublets were excluded and live cells were analyzed using forward scatter (FSC) and side scatter (SSC) live-dead exclusion. Single cell analysis software (FlowJo) was used to analyze cell cytometric data.
Gating strategy (mouse). Cardiac macrophages were identified as CD45 + CD11b + CD64 + and were further parsed by CCR2, MHC-II, Timd4, Lyve1 and Td. Infiltrating monocytes in the myocardium were identified as CD45 + CD11b + CD64 + Ly6C + . Blood monocytes were identified as CD115 + CD11b + Ly6C + . Brain microglia were identified as CD45 lo CD11b + F4/80 + CD64 + . Liver macrophages were identified as CD45 + F4/80 + CD11b + MHC-II hi . Neutrophils were identified as CD45 + CD11b + CD64 − Ly6G + . Lymphocytes were identified as CD45 + CD64 − CD11b − .
Gating strategy (human). Cardiac macrophages were identified as CD45 + CD64 + MerTK + CD14 + and were further parsed by CCR2 and HLA-DR.
Mouse antibodies. We used antibodies to CD45 (30-F11), CD64 (X54-5/7.1), CD11c (N418), MHC-II (AF6-120.1), CD11b (M1/70), Timd4 (RMT4-54), Ly6C (HK1.4), CD115 (AF598), Ly6g (1A8), F4/80 (CI:A3-1), CD4 (RM4-5); CD8a (53-6.7), CD3e (145-2c11) and BrdU (Bu20a), as well as TruStain CD16/CD32 FC Block (93).
Human antibodies. We used antibodies to CD45 (HI30), MerTK (2B10C42), CD14 (M5E2), CD64 (10.1), CCR2 (K036C2) and HLA-DR (L243).
All mouse and human antibodies listed above were purchased from Biolegend, with the exception of antibodies to CCR2 (475301, R&D Systems), Lyve1 (ALY7, eBiosciences) and B220 (RA3-6B2); BV421-SA (BD Biosciences). Antibody clones are provided in parentheses. For more details, see the Nature Research Reporting Summary.
Myocardial infarction model. All left anterior descending artery ligations were performed as described 44 . Briefly, after shaving of the chest and 2% isofluorane induction of anesthesia (0.8 L min -1 oxygen), mice were intubated and ventilated with a pressure-control ventilator (Kent Scientific). The thorax and pericardium were opened, and using a 7-0 silk suture (Deknatel), the left anterior descending artery was ligated, the chest was closed, and the animal recovered with an immediate 0.1 mg kg -1 subcutaneous injection of buprenorphine, followed by another injection 24 h later. Control mice are those with unopened chests.
Parabiosis. The lateral aspects of female donor mice (left) and recipient mice (right) were shaved and matching skin incisions were made from behind the ear to the tail of each mouse, as we previously described 5 . The subcutaneous fascia was dissected to create ~0.5 cm of free skin. The olecranon and knee joints were attached by a mono-nylon 5.0 suture (Ethicon) and the dorsal and ventral skins were attached by continuous suture. Animals recovered with an immediate 0.1 mg kg -1 subcutaneous injection of buprenorphine followed by another injection 24 h later. Maintenance subcutaneous saline injections were given for 1 week as well as 3% neomyocin antibiotics for 2 weeks. Mice were joined for 2-6 months. The percentage chimerism for each macrophage subset was normalized to blood monocytes in the recipient mouse that originated from the donor and expressed as a percentage (Normalized chimerism (%) = (Donor cells in recipient (%) / Ly6C hi monocyte donor cells in recipient (%)) × 100).
Bone marrow chimeras.
Adult wild-type mice (CD45.1) were sublethally irradiated twice with 628 cGy with 3 h in between. Chimeras were made with CD45.1 C57BL/6 hosts receiving ~5 × 10 6 bone marrow cells from CD45.2 C57BL/6 mice (Cx3cr1 creER-YFP :R26 Td ) on the day of irradiation. Irradiation was performed using a Gammacell 40 exactor. For shielded bone marrow chimeras, the same irradiation was performed with the addition of a 1 cm-thick lead shield covering the thoracic cavity of the mouse using an XRAD320 irradiator. All animals received 3% neomycin antibiotics for 2 weeks.
Cell sorting. Mouse hearts were isolated and enzymatically digested as described 5 , with the inclusion of 1 mM flavopiridol in the digestion buffer. Digestions were Sequencing. The molarity of each library was calculated based on library size as measured by bioanalyzer (Agilent Technologies) and quantitative PCR amplification data (Kappa/Roche). Samples were pooled and normalized to 10 nM, and then diluted to 2 nM using elution buffer (Qiagen) with 0.1% Tween 20 (Sigma). Each 2 nM pool was denatured using 0.1 N NaOH at equal volumes for 5 min at room temperature. Library pools were further diluted to 20 pM using HT-1 (Illumina) before being diluted to a final loading concentration of 14 pM. Some 150 μ l from the 14 pM pool was loaded into each well of an 8-well strip tube and loaded onto a cBot (Illumina) for cluster generation. Samples were sequenced on a HiSeq 2500 with the following run parameters: read 1, 26 cycles; read 2, 98 cycles; index 1, 8 cycles.
Single-cell RNA sequencing analysis. The sequenced data were processed into expression matrices with the Cell Ranger Single Cell software suite 1.3.1 by 10x Genomics (http://10xgenomics.com/). Raw base-call files from HiSeq2500 sequencer were demultiplexed into library-specific FASTQ files. Sequencing reads were aligned to the mouse transcriptome using STAR aligner 45 . Subsequently, cell barcodes and unique molecular identifiers underwent filtering and correction. Reads associated with the retained barcodes were quantified and used to build a transcript count table.
The standard procedures of filtering, variable gene selection, dimensionality reduction and clustering were performed using the scRNA-seq analysis R package Seurat (v.2.3.0) 46 . To exclude low-quality cells in both single-cell experiments, we filtered cells that expressed fewer than 200 genes per 1,000 unique molecular identifiers, and to exclude probable doublets, cells with > 5,800 unique molecular identifiers were removed.
All genes that were not detected in at least three single cells were excluded. Based on these criteria, 12,916 genes across 1,590 samples in the macrophagedendritic cell data set and 15,147 genes across 6,473 samples (1,783 control macrophages and 4,690 post-infarct macrophages) in the control-myocardial infarction data set remained for downstream analysis. To reduce biases caused by technical variation, sequencing depth and capture efficiency, normalization was performed using the deconvolution approach of Lun et al. 47 as implemented in R packages Scran (1.6.2) 47 and Scater (1.6.0) 48 . This normalization method pools expression counts from linear size groups of cells. These group-specific size factors are than deconvolved into cell-specific size factors that are used to scale the counts of individual cells.
The expression matrix underwent dimensionality reduction using principal component analysis. We first selected genes with high variance using the FindVariableGenes function with log-mean expression values between 0.06 and 2 for the macrophage-dendritic cell data and 0.0125 and 1.5 for the controlmyocardial infarction data, and dispersion (variance/mean) between 0.5 and 30 for both data sets. The number of highly variable genes based on these criteria were 1,344 genes for the macrophage-dendritic cell data set, and 1,242 genes for the control-myocardial infarction data set. Principal component analysis was performed on the selected variable genes and 15 and 20 significant principal components were identified for downstream analysis of the macrophage-dendritic cell and control-myocardial infarction data, respectively. The number of significant principal components to include in downstream analysis was determined based on the elbow point on the plot of standard deviations of principal components.
Clusters were identified by a graph-based clustering approach implemented by the FindCluster function in Seurat. Cells were embedded in a k-nearest neighbors graph based on the euclidean distance matrix constructed on the significant principal components. The Louvian modularity optimization algorithm 49 was applied to iteratively group cells together into clusters. We employed t-SNE for dimensionality reduction and visualization of our data sets.
The modularity-based clustering is a sensitive method that can occasionally overpartition larger clusters to detect rare populations. We therefore merged together very transcriptionally similar clusters (with no significant differential gene expression). In addition, two small clusters of contaminating B cells (enriched in Cd79b, Cd79a, Ly6d and Ptprcap) and stromal cells (enriched in Sparc, Fabp4, Igfbp7 and Crip2) were removed from the control-myocardial infarction data set before any subsequent analysis.
For all single-cell differential expression tests, we used the model-based analysis of single-cell transcriptomics (MAST) test 50 
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Cell population abundance and confirmed in our data analysis.
Gating strategy
For all experiments an initial gaiting strategy was used to gait on live (based on SSC-A/FSC-A) cells followed by two double exclusion gates (FSC-W/FSC-H and SSC-W/SSC-H) and a total CD45+ gate. Subsequent gates are defined in the figures/figure legends.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
